Product NDC: | 0115-1245 |
Proprietary Name: | Minocycline Hydrochloride |
Non Proprietary Name: | Minocycline Hydrochloride |
Active Ingredient(s): | 45 mg/1 & nbsp; Minocycline Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0115-1245 |
Labeler Name: | Global Pharmaceuticals, Division of Impax Laboratories Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090024 |
Marketing Category: | ANDA |
Start Marketing Date: | 20090203 |
Package NDC: | 0115-1245-01 |
Package Description: | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0115-1245-01) |
NDC Code | 0115-1245-01 |
Proprietary Name | Minocycline Hydrochloride |
Package Description | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0115-1245-01) |
Product NDC | 0115-1245 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Minocycline Hydrochloride |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20090203 |
Marketing Category Name | ANDA |
Labeler Name | Global Pharmaceuticals, Division of Impax Laboratories Inc. |
Substance Name | MINOCYCLINE HYDROCHLORIDE |
Strength Number | 45 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Tetracycline-class Drug [EPC],Tetracyclines [Chemical/Ingredient] |